Same or Not the Same? Comparison of Adipose Tissue-Derived Versus Bone Marrow-Derived Mesenchymal Stem and Stromal Cells
Top Cited Papers
- 3 April 2012
- journal article
- review article
- Published by SAGE Publications in Stem Cells and Development
- Vol. 21 (14) , 2724-2752
Abstract
Mesenchymal stem/stromal cells (MSCs) comprise a heterogeneous population of cells with multilineage differentiation potential, the ability to modulate oxidative stress, and secrete various cytokines and growth factors that can have immunomodulatory, angiogenic, anti-inflammatory and anti-apoptotic effects. Recent data indicate that these paracrine factors may play a key role in MSC-mediated effects in modulating various acute and chronic pathological conditions. MSCs are found in virtually all organs of the body. Bone marrow-derived MSCs (BM-MSCs) were discovered first, and the bone marrow was considered the main source of MSCs for clinical application. Subsequently, MSCs have been isolated from various other sources with the adipose tissue, serving as one of the alternatives to bone marrow. Adipose tissue-derived MSCs (ASCs) can be more easily isolated; this approach is safer, and also, considerably larger amounts of ASCs can be obtained compared with the bone marrow. ASCs and BM-MSCs share many biological characteristics; however, there are some differences in their immunophenotype, differentiation potential, transcriptome, proteome, and immunomodulatory activity. Some of these differences may represent specific features of BM-MSCs and ASCs, while others are suggestive of the inherent heterogeneity of both BM-MSC and ASC populations. Still other differences may simply be related to different isolation and culture protocols. Most importantly, despite the minor differences between these MSC populations, ASCs seem to be as effective as BM-MSCs in clinical application, and, in some cases, may be better suited than BM-MSCs. In this review, we will examine in detail the ontology, biology, preclinical, and clinical application of BM-MSCs versus ASCs.Keywords
This publication has 277 references indexed in Scilit:
- Functional Assessment of Adipose Stem Cells for Xenotransplantation Using Myocardial Infarction Immunocompetent Models: Comparison with Bone Marrow Stem CellsCell Biochemistry and Biophysics, 2011
- Bone Marrow Stromal Cells Produce Long-Term Pain Relief in Rat Models of Persistent PainStem Cells, 2011
- Human Mesenchymal Stem Cells Reprogram Adult Cardiomyocytes Toward a Progenitor-Like State Through Partial Cell Fusion and Mitochondria TransferStem Cells, 2011
- Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?Stem Cells, 2010
- Stromal stem cells from adipose tissue and bone marrow of age‐matched female donors display distinct immunophenotypic profilesJournal of Cellular Physiology, 2010
- Acceleration of spinal fusion using syngeneic and allogeneic adult adipose derived stem cells in a rat modelJournal of Orthopaedic Research, 2009
- Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing mediumBone Marrow Transplantation, 2008
- IFN‐γ activation of mesenchymal stem cells for treatment and prevention of graft versus host diseaseEuropean Journal of Immunology, 2008
- Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspiratesJournal of Cellular Physiology, 2006
- Surface protein characterization of human adipose tissue‐derived stromal cellsJournal of Cellular Physiology, 2001